The other day, I wrote about ObamaCare’s war on kids and seniors. Well, as the NYT reports, it’s even worse than we thought:
In an unintended consequence of the new health care law, drug companies have begun notifying children’s hospitals around the country that they no longer qualify for large discounts on drugs used to treat rare medical conditions.
The government has long required drug companies to give discounts to hospitals caring for large numbers of low-income people. And, during the Bush years, they expanded that to include children’s hospitals.
But this year Congress, in revising the drug discount program as part of the new health care law, blocked these hospitals from continuing to receive price cuts on orphan drugs …
The NYT goes out of its way to say that this will affect ONLY 200,000 people, but they wouldn’t be doing so if they were writing about a Republican health care law. Here’s what the change really means:
Joshua D. Greenberg, vice president of Children’s Hospital Boston, said that loss of the discounts ‘jeopardizes our ability to care for some of the sickest children with the most complex health care needs.’
This is “change you can believe in,” alright. And you can bet your bottom dollar that this isn’t the “honest mistake” the NYT reports, but part ofa deal to keep the drug companies on board with “reform.”
But hey it isn’t “rationing,” and there are no “death panels,” right?
[ht Doug Powers]
Post a Comment